Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorPolat, Mualla
dc.contributor.authorKarapinar, Tekden
dc.contributor.authorKüçükyangöz, Belgin
dc.contributor.authorBiçer, Yusuf Özgür
dc.contributor.authorUzun, Özge
dc.contributor.authorSezer, Tuna
dc.date.accessioned2023-01-31T12:05:01Z
dc.date.available2023-01-31T12:05:01Z
dc.date.issued2021en_US
dc.identifier.citationPOLAT, M., KARAPINAR, T., KÜÇÜKYANGÖZ, B., BİÇER, Y. Ö., Özge, U. Z. U. N., & SEZER, T. (2021). Evaluation of Sense of Smell in Onychomycosis Patients Receiving Terbinafine Treatment. Duzce Medical Journal, 23(3), 294-298.en_US
dc.identifier.issn1307-671X
dc.identifier.urihttps.//doi.org/10.18678/dtfd.1010177
dc.identifier.urihttps://hdl.handle.net/20.500.12294/3224
dc.description.abstractAim: The most common side effects of terbinafine are gastrointestinal symptoms. Loss of taste and smell side effects are presented in a small number of case reports. We aimed to measure the effect of terbinafine on the sense of smell and the degree of change in the sense of smell in this study. Material and Methods: Odor identification test (OIT), odor threshold test (OTT), and odor discrimination test (ODT) were applied to the patients treated with terbinafine and the control group. It was applied with “Sniffin Sticks” test pens. Smell test was performed on the patient group just before the start of terbinafine treatment and at the end of 3 months of treatment. Results: There was no statistical difference between the patient and control groups in terms of age (p=0.991) and gender (p=0.811). There was no statistical difference when the initial odor tests of the patient group and the control group were compared. The OIT value of the patient group was 10.15±1.43 at the beginning and 10.10±1.15 at the end of the treatment (p=0.743). The OTT values were 6.23±1.08 at the beginning and 6.21±0.85 at the end of the treatment (p=0.811). The ODT values were 9.71±1.44 at the beginning and 9.69±1.34 at the end of the treatment (p=0.767). There was no statistical difference in the results of the tests performed at the beginning and end of the treatment. Conclusion: There was no adverse effect on the sense of smell associated with the use of systemic terbinafine treatment for 3 months. © 2021, Duzce University Medical School. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherDuzce University Medical Schoolen_US
dc.relation.ispartofDuzce Medical Journalen_US
dc.identifier.doi10.18678/dtfd.1010177en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectOdoren_US
dc.subjectOnychomycosisen_US
dc.subjectSniffin’Sticks Testen_US
dc.subjectTerbinafineen_US
dc.titleEvaluation of Sense of Smell in Onychomycosis Patients Receiving Terbinafine Treatmenten_US
dc.title.alternativeTerbinafin Tedavisi Alan Onikomikoz Hastalarında Koku Duyusunun Değerlendirilmesien_US
dc.typearticleen_US
dc.departmenttıp Fakültesi, Dahili tıp Bilimlerien_US
dc.authorid0000-0003-0290-5498en_US
dc.identifier.volume23en_US
dc.identifier.issue3en_US
dc.identifier.startpage294en_US
dc.identifier.endpage298en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.institutionauthorUzun, Özge
dc.authorscopusid7007089316en_US
dc.identifier.scopus2-s2.0-85125340799en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster